RhoGAP domain-containing fusions and PPAPDC1A fusions are recurrent and prognostic in diffuse gastric cancer.

We conducted an RNA sequencing study to identify novel gene fusions in 80 discovery dataset tumors collected from young patients with diffuse gastric cancer (DGC). Twenty-five in-frame fusions are associated with DGC, three of which (CLDN18-ARHGAP26, CTNND1-ARHGAP26, and ANXA2-MYO9A) are recurrent in 384 DGCs based on RT-PCR. All three fusions contain a RhoGAP domain in their 3' partner genes. Patients with one of these three fusions have a significantly worse prognosis than those without. Ectopic expression of CLDN18-ARHGAP26 promotes the migration and invasion capacities of DGC cells. Parallel targeted RNA sequencing analysis additionally identifies TACC2-PPAPDC1A as a recurrent and poor prognostic in-frame fusion. Overall, PPAPDC1A fusions and in-frame fusions containing a RhoGAP domain clearly define the aggressive subset (7.5%) of DGCs, and their prognostic impact is greater than, and independent of, chromosomal instability and CDH1 mutations. Our study may provide novel genomic insights guiding future strategies for managing DGCs.

Narrowing Plasmon Resonance Linewidth of Au Nanodome Lattices.

Gold hollow nanodomes arranged in hexagonal lattices support surface plasmon polaritons (SPPs) propagating at air-Au interface. The cross-sectional heights of the continuous and hierarchical hexagonal nanodome arrays can be altered by a simple thermal treatment, and the change in nanodome size leads to a significant linewidth narrowing of plasmon resonance because of reduced scattering loss. Taking the variation in the SPP intensities into account, the surface modulation depth is found to be around 100 nm for achieving a longer propagation length of SPP.

Sporadic Early-Onset Diffuse Gastric Cancers Have High Frequency of Somatic CDH1 Alterations, but Low Frequency of Somatic RHOA Mutations Compared With Late-Onset Cancers.

BACKGROUND & AIMS: Early-onset gastric cancer, which develops in patients younger than most gastric cancers, is usually detected at advanced stages, has diffuse histologic features, and occurs more frequently in women. We investigated somatic genomic alterations associated with the unique characteristics of sporadic diffuse gastric cancers (DGCs) from younger patients. METHODS: We conducted whole exome and RNA sequence analyses of 80 resected DGC samples from patients 45 years old or younger in Korea. Patients with pathogenic germline mutations in CDH1, TP53, and ATM were excluded from the onset of this analysis, given our focus on somatic alterations. We used MutSig2CV to evaluate the significance of mutated genes. We recruited 29 additional early-onset Korean DGC samples and performed SNP6.0 array and targeted sequencing analyses of these 109 early-onset DGC samples (54.1% female, median age, 38 years). We compared the SNP6.0 array and targeted sequencing data of the 109 early-onset DGC samples with those from diffuse-type stomach tumor samples collected from 115 patients in Korea who were 46 years or older (late onset) at the time of diagnosis (controls; 29.6% female, median age, 67 years). We compared patient survival times among tumors from different subgroups and with different somatic mutations. We performed gene silencing of RHOA or CDH1 in DGC cells with small interfering RNAs for cell-based assays. RESULTS: We identified somatic mutations in the following genes in a significant number of early-onset DGCs: the cadherin 1 gene (CDH1), TP53, ARID1A, KRAS, PIK3CA, ERBB3, TGFBR1, FBXW7, RHOA, and MAP2K1. None of 109 early-onset DGC cases had pathogenic germline CDH1 mutations. A higher proportion of early-onset DGCs had mutations in CDH1 (42.2%) or TGFBR1 (7.3%) compared with control DGCs (17.4% and 0.9%, respectively) (P < .001 and P = .014 for CDH1 and TGFBR1, respectively). In contrast, a smaller proportion of early-onset DGCs contained mutations in RHOA (9.2%) than control DGCs (19.1%) (P = .033). Late-onset DGCs in The Cancer Genome Atlas also contained less frequent mutations in CDH1 and TGFBR1 and more frequent RHOA mutations, compared with early-onset DGCs. Early-onset DGCs from women contained significantly more mutations in CDH1 or TGFBR1 than early-onset DGCs from men. CDH1 alterations, but not RHOA mutations, were associated with shorter survival times in patients with early-onset DGCs (hazard ratio, 3.4; 95% confidence interval, 1.5-7.7). RHOA activity was reduced by an R5W substitution-the RHOA mutation most frequently detected in early-onset DGCs. Silencing of CDH1, but not RHOA, increased migratory activity of DGC cells. CONCLUSIONS: In an integrative genomic analysis, we found higher proportions of early-onset DGCs to contain somatic mutations in CDH1 or TGFBR1 compared with late-onset DGCs. However, a smaller proportion of early-onset DGCs contained somatic mutations in RHOA than late-onset DGCs. CDH1 alterations, but not RHOA mutations, were associated with shorter survival times of patients, which might account for the aggressive clinical course of early-onset gastric cancer. Female predominance in early-onset gastric cancer may be related to relatively high rates of somatic CDH1 and TGFBR1 mutations in this population.

Morphology-Directed Selective Production of Ethylene or Ethane from CO2 on a Cu Mesopore Electrode.

The electrocatalytic conversion of CO2 to value-added hydrocarbons is receiving significant attention as a promising way to close the broken carbon-cycle. While most metal catalysts produce C1 species, such as carbon monoxide and formate, the production of various hydrocarbons and alcohols comprising more than two carbons has been achieved using copper (Cu)-based catalysts only. Methods for producing specific C2 reduction outcomes with high selectivity, however, are not available thus far. Herein, the morphological effect of a Cu mesopore electrode on the selective production of C2 products, ethylene or ethane, is presented. Cu mesopore electrodes with precisely controlled pore widths and depths were prepared by using a thermal deposition process on anodized aluminum oxide. With this simple synthesis method, we demonstrated that C2 chemical selectivity can be tuned by systematically altering the morphology. Supported by computational simulations, we proved that nanomorphology can change the local pH and, additionally, retention time of key intermediates by confining the chemicals inside the pores.

Interfacial Mode Interactions of Surface Plasmon Polaritons on Gold Nanodome Films.

Hollow metallic nanodome structures were fabricated using anodized aluminum oxide (AAO) nanopores as deposition and sacrificial templates. Individual Au nanodomes inherit the unique shapes of the well-defined AAO membranes whose pedestal cells become square or hexagonal lattices with hemispheres in close proximity. Minimal contact between the hollow nanodomes and the glass substrate provide an identical dielectric medium across the film. The nanodome Au films support surface plasmon polaritons (SPPs) of strong air-Au and weak Au-glass modes in the light transmission dispersions. The mode crossings of distinct SPPs exhibit characteristic energy gaps, which depend on the periodic geometries of the nanostructures.